342
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Parkinson' Disease and Neuropsychological Assessment

&
Pages 1-18 | Received 12 Sep 1998, Published online: 07 Jul 2009

References

  • Barbeau A. Etiology of Parkinson's disease: A research strategy. Canadian Journal of Neurological Science 1984; 24: 24–28
  • Baumann R. J., Jameson H. D., McKcan H. E., Haack D. G., Weisberg L. M. Cigarette smoking and Parkinson's disease: A comparison with matched neighbors. Neurology 1980; 30: 839–843
  • Becker J. B., Robinson T. E., Barton P., Sintov A., Rivka S., Levy R. J. Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled 1990
  • Bernheimer H., Birkmayer W., Hornykicwcz O., Jellinger K., Geitelberger F. Genetic susceptibility, environmental factors and Parkinson's disease. Paper presented at the VIIth International Symposium on Parkinson's Disease. 1985
  • Bernheimer H., Birkmayer W., Hornykicwcz O., Jellinger K., Geitelberger F. Brain dopamine and the syndroms of Parkinson and Huntington. Journal of Neurological science 1973; 20: 455
  • Bharucha N. E., Stokes L., Schoenberg B. S., Ward C., Ince S., Nutt J. G., Eldridge R., Calne D. B., Mantel N., Duvoisin K. A case-control study of twin pairs discordant for Parkinson's disease: A search for environmental risk factors. Neurology 1986; 36: 284–288
  • Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neurosciences 1990; 37: 296–302
  • Bodis-Wollner I., Yahr M. D., Mylin I., Thornton J. Dopaminergic dcficieny and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
  • Bodis-Wollner I., Harnois C., Robak P., Mylin L. On the possible role of temporal delays of afferent processing in Parkinson's disease. Journal of Neural Transmission 1983; 19: 243–252
  • Boller F., Passafiume D., Keefe N. C., Rogers K., Morrow L., Kim Y. Visuospatial impairment in Parkinson's disease. Archives of Neurology 1984; 41: 485–490
  • Botez M. I., Barbeau A. Neuropsychological findings in Parkinson's disease: A comparison between various tests during long-term levodopa therapy. International Journal of Neurology 1975; 10: 222–232
  • Bowen F., Burns M., Brady E., Yahr M. Parkinsonism: Effects of levodopa treatment on concept formation. Neurology 1975; 25: 701–704
  • Bowen F., Yahr M. Behavioral alterations in patients with basal ganglia lesions. The basal ganglia, M. Yahr. Raven Press, New York 1976; 169–180
  • Brown R. G., Marsden C. D. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988; 111: 323–345
  • Brown R. G., Marsden C. D. Visuospatial function in Parkinson's disease. Brain 1986; 109: 987–1002
  • Burke W. J., Peterson J., Rubin E. H. Electoconvulsive therapy in the treatment of combined depression and Parkinson's disease. Psychosomatics 1988; 29(2)341–345
  • Burns R. B., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitx D. M., Kopin J. A primate model of parkinsonism: selective destruction of dopaminerpic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1. 2,3, 6-tetrahydropyridine 1983
  • Carlsson A., Lindquist M., Tagnusson T. 3,4-dihydroxyphenylalanine and 5-Hydroxytryptophan as reserpine antagonists. Nuture 1957; 180: 1200
  • Carlson N. R. Foundations of physiological psychology. Allyn and Bacon. Inc, Boston 1988
  • Cools A., Van den Berken J., Horstinek M., Van Spaendonek K., Berger H. Cognitive and motor shifting aptitude in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1984; 47: 443–453
  • Cummings J. L., Benson F. Subcortical dementia. Archives of Neurology 1984; 41: 874–879
  • Cummings J. L., Benson F. Psychological dysfunction accompanying subcortical denientias. Annual Review of Medicine 1988; 39: 53–61
  • Delwaide P. J., Gonce M. Pathophysiology of Parkinson's signs. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 59–74
  • Della Sala S., DiLorenzo G., Giordana A., Spinnler H. Directional forecast: A specific visuo-spatial impairment of parkinsonians. Journal of Neurology, Neurosurgery, and Psychiatry 1986; 49: 1258–1265
  • Direnfeld L., Albert M., Volicer L., Langlais P., Marquis J., Kaplan E. Parkinson's disease: The possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology 1984; 41: 935–941
  • Duvoisin R. C. Parkinson's disease: A guide for patient and family. Raven Press, New York 1991
  • Duvoisin R. C., Gearing F. R., Schweitzer M. D., Yahr M. D. A family study of parkinsonism. Progress in Neurogenetics, A. Barbeau, J. R. Brunette. Excerpta Medica, Amsterdam 1969; 492–496
  • Evarts E. V., Teravainen H., Calne D. B. Reaction time in Parkinson's disease. Brain 1981; 104: 167–186
  • Fahn S., Tolosa E., Marin C. Clinical rating scale for tremor. Parkinson's disease an movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 225–234
  • Folstein M. F., Folsein S. E., McHugh P. R. “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Reaserch 1975; 12: 189–198
  • Gaudin D. P., Rioux L., Bedard P. J. Fetal Da neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-DOPA in the rat. Brain Research 1990; 506(1)166–168
  • Gelenberg A. J., Bassuk E. L., Schoonover S. C. The practioner's guide to psychoactive drugs (3rd ed.). Plenum Medical Book Company, New York, NY 1991
  • Gershanik O. S. Parkinsonism of early onset. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 191–204
  • Gibb W. R. The neuropathology of parkisonian disorders. Parkinson's and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 205–224
  • Godwin-Austen R. B., Lee P. N., Marmot M. G., Stern G. M. Smoking and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1982; 45: 577–581
  • Golbe L. I., Duvoisin R. C. The epidemiology of and natural history of Parkinson's disease. The comprehensive management of Parkinson's disease, M. B. Stern, H. I. Hurtig. PMA Publishing Corp, New York 1988; 51–62
  • Gotham A. M., Brown R. G., Marsden C. D. “Frontal” cognitive function in patients with Parkinson's disease “on” and “off” levodopa. Brain 1988; 111: 299–321
  • Grimes J. D., Hassan M. N., Preston D. N. Adverse neurologic effects of metaclopramide. Canadian Medical Association Journal 1982; 126: 23–52
  • Gronwall D. Paced auditory serial addition task: A measure of recovery from concussion. Perceptual and Motar Skills 1977; 44: 367–373
  • Hardie R. J. Problems and unanswered questions concerning levodopa treatment in Parkinson's disease. Acta Neurologica-Scandinavia 1989; 80(126)77–82
  • Hardie R. J., Lees A. J. Neuroleptic-induced Parkinson's syndrome: Clinical features and results of treatment with levodopa. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51(6)433–446
  • Heinonen E. H., Rinne U. K. Selegiline in the treatment of Parkinson's Disease. Acta Neurologica-Scandinavia 1989; 80(126)103–111
  • Hietanen M., Teravainen H. Cognitive performance in early Parkinson's disease. Acta Neurologica Scandinavica 1986; 73: 151–159
  • Hovestadt A., De Jong G. J., Meerwaldt J. D. Spatial disorientation as an early symptom of Parkinson's disease. Neurology 1987; 37: 485–487
  • Huber S. J., Shulman H. G., Paulson G. W., Shuttleworth E. C. Dose-dependent memory impairment in Parkinson's disease. Neurology 1989; 39: 438–440
  • Huber S. J., Shuttleworth K. C., Paulson G. W. Dementia in Parkinson's disease. Archives of Neurology 1986; 43: 987–990
  • Hutton J. T., Dippel R. L. Caring for the Parkinson patient. Prometheus Books, Buffalo 1989
  • Irwin I., Langston J. W., DeLanney I. E. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP- concentrations and neurotoxicity. Life Sciences 1987; 40: 731–740
  • Jankovic J., Marsden C. D. Therapeutic strategies in Parkinson's Disease. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimaore 1988; 95–120
  • Jankovic J., Tolosa E. Parkinson's disease and movement disorders. Urban and Schwarzenburg, Baltimore 1988
  • Jenner P., Marsden C. D. MPTP-induced parkinsonism as an experimental model of Parkinson's disease. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 37–48
  • Karayandis F. Parkinson's disease: A conceptualization of neuropsychological deficits within an information-processing framework. Biological Psychology 1989; 29: 149–179
  • Kaufman A. S. Intelligence testing with the WISC-R. John Wile & Sons. Inc, New York, NY 1979
  • Klawans H. L., Stein R. W., Tanner C. M., Goetz C. G. A pure parkinsonian syndrome following acute carbon monoxide intoxication. Archives of Neurology 1982; 39: 302
  • Lang A. E. The genetics of Parkinson's disease. Handbook of Parkinson's disease, F. S. Livingston. Marcel Dekker, New York 1987
  • Langston J. W. The etiology of Parkinson's disease: New directions for research. Parkinson's disease and movement disorders, J. Jankovic, E. Tolosa. Urban and Schwarzenburg, Baltimore 1988; 75–86
  • Lees A., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257–270
  • Lewin R. Parkinson's disease: An environmental cause. Science 1985; 229: 979–980
  • Lewy F. H. Neurological, medical and biochemical signs and symptoms indicating chronic industrial carbon disulphide absorption. Annuals of International Medicine 1941; 15: 869–883
  • Lieberman A. N. Update on Parkinson's disease. New York Stale Journal of Medicine 1987; 87(3)147–153
  • Marsden C. D. Defects of movement in Parkinson's disease. Restorative Neurology, 2, Clinical Neurophysiology in Parkinsonism, Declwaide, Agnoli, 1985; 107–115
  • Marttila R. J., Kaprio J., Koshenvuo M., Rinne U. K. Finnish Parkinson's disease twin study: Preliminary results. Upsula Journal of Medical Science 1986; 43: 93
  • Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric psychiatry, L. Bellak, T. Karasu. Grune and Stratton, New York 1976; 77–121
  • Mayeux R. The psychiatric and sexual complications of Parkinson's disense. Medical Aspects of Human Sexuality 1987; 21(3)68–72
  • Mortimer J. A., Pirozzolo F. J., Hansch E. C., Webster. Relationship of motor symptoms to the intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–137
  • Nissenbaum H., Quinn N. P., Brown K. G., Toone B. K., Gotham A. M., Marsden C. D. Mood swings associated with the “on-olf” phenomenon in Parkinson's disease. Psychological Medicine 1987; 17(4)899–904
  • Ogawa T. Personality characteristics of Parkinson's disease. Perception and Motor Skills 1981; 52: 375–378
  • Ostergaard K., Dupont E. Slozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease. Acta Neurologiaca-Scandinavia 1988; 78(4)349–350
  • Parkinson J. Essay on the shaking palsy. Sherwood. Neely, and Jones, London 1817
  • Peters H. A., Levine R. L., Matthews C. J., Chapman L. J. Extrapyramidal symptoms from carbon disulphide exposure in grain storage workers. Neurology 1981; 36: 342
  • Pierce J. R. Living with Parkinson's disease. Spectrum Communications, Knoxville, Tenn 1989
  • Pillon B., Dubois B., Lhermitte F., Agid Y. Heterogencity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986; 36: 1179–1185
  • Pillon B., Dubois B., Bonnet A. M., Esteguy M., Guimataes J., Vigouret J. M., Lhermitte F., Agid Y. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15 objects test. Neurology 1989; 39: 762–768
  • Pitcairn T. K., Clemic S., John G. M., Pentland B. Non-verbal cues in the self-presentation of Parkinsonian patients. British Journal of Clinical Psychology 1990; 29(2)177–184
  • Poewe W., Gerstenbrand F., Ransmayr G., Plorer S. Premorbid personality of Parkinson patients. Journal of Neural Transmission 1983; 19: 215–242
  • Rafal R., Posner M., Walsker J., Friedrich F. Cognition and the basal ganglia. Brain 1984; 107: 1083–1094
  • Raskin S. A., Borod J. C., Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychology Review 1990; 1(3)185–221
  • Rajput A. H., Offord K. P., Beard C. M., Durland L. T. Annals of Neurology 1984; 16: 278–282
  • Rajput A. H., Stern W., Christ A., Laverty W. Etiology of Parkinson's disease: Environmental Fector(s). Neurology 1984; 34: 207
  • Reitan K., Boll T. Intellectual and cognitive functions in Parkinson's disease. Journal of Consulting and Clinical Psychology 1971; 37: 364–369
  • Riederer P., Wutctich S. Time course of nigrostriatal degeneration in Parkinson's disease. Jouranl of Neural Transmission 1976; 38: 277–301
  • Rinne U. K. Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurologica Scandinavia 1983; 68: 19–26
  • Rinne U. K., Sonninen V. Acid monamine metabolites in the cerebral spinal fluid of patients with Parkinson's disease. Neurology 1972; 22: 62–69
  • Rinne J. O., Rummukainen J., Paljarvi L., Rinne U. K. Dementia in Parkinson's disease is related to neuronal loss in the medial SN. Annals of Neurology 1989; 26(1)47–50
  • Roy M., Boyer L., Barbeau A. A prospective study of 50 cases of familial Parkinson's disease. Canadian Journal of Neurological Science 1983; 10: 37–42
  • Sahakian B. J., Morris R. G., Evenden J. L., Heald A., Levy R., Philpot M., Robbins T. W. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988; 111: 695–718
  • Scholz O. B., Sastry M. Memory characteristics in Parkinson's disease. International Journal of Neuroscience 1985; 27: 229–234
  • Schultz W. Recent physiological and pathophysiological aspects of parkinsonian movement disorders. Life Sciences 1984; 34(23)2213–2223
  • Silver J. M., Hales R. H., Yudofsky S. C. Psychoparmacology of depression in neutologic disorders. Paper presented at the 142nd. Annual Meeting of the American Psychiatric Association 1990; 51: 33–39, suppl
  • Starkstein S., Leiguarda R., Gershan O., Berthier M. Neuropsychological disturbance in hemiparkinson's disease. Neurology 1987; 37: 1762–1764
  • Stein M. B., Heuser I. J., Juncos J. L., Thomas W. U. Anxiety disorders in patients with Parkinson's disease. American Journal of Psychiatry 1990; 147(2)217–220
  • Stern M. B. The clinical characteristics of Parkinson's disease and parkinsonian syndroms: Diagnosis and assessment. The comprehensive management of Parkinson's disease, M. B. Stern, H. I. Hurtig. PMA Publishing Corp, New York 1988; 3–50
  • Stern M. B., Hurtig H. I. The comprehensive management of Parkinson's disease. PMA Publishing Corp, New York 1988
  • Stern G., Lees A. J. Parkinson's disease. The facts. Oxford University Press, New York 1990
  • Stern Y., Sano M., Mayeux R. Comparisons of dementia and intellectual change in Parkinson's and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology 1987; 9: 66
  • Sluss D., Benson D. F. The frontal lobes. Raven, New York 1986
  • Tanner C. M. Influence of environmental factors on the onset of Parkinson's disease. Neurology 1986; 36: 215
  • Taylor A. F., Saint-Cyr J. A., Lang A. E. Parkinson's disease: Cognitive changes in relation to treatment response. Brain 1987; 110: 35–51
  • Taylor A. F., Saint-Cyr J. A., Lang A. F. Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow. Brain 1986; 109: 845–883
  • Tweedy J. R., Langer K. G., McDowell F. H. The effect of semantic relations on the memory deficit associated with Parkinson's disease. Journal of Clinical Neuropsychology 1982; 4: 235–247
  • Lopp B. Toward a better understanding of Parkinson's disease. Geriatric Nursing 1987; 8(4)180–182
  • Litti R. J., Rajput A. H., Ashenburst E. M., Rosdilsky B. Cyanide-induced parkinsonism: A clinicopathologic report. Neurology 1985; 35: 921–925
  • Ward C. D. Soes selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study. Journal of Neurology, Neurosurgery, and Psychiatry 1994; 57(2)217–220
  • Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983; 33: 815–824
  • Weingartner H., Burns S., Diebel R., LeWitt P. Cognitive impairments in Parkinson's disease: Distinguishing between effort-demanding and qutomatic cognitive processes. Psychiatric Research 1984; 11: 223–235
  • Whitehouse P. J., Price D. I., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982; 215: 1237–1239
  • Yochoki M. Juvenile Parkinson's disease: Clinical aspects. Advanes in Neurological Sciences 1979; 23: 1048–1059
  • Yochoki M., Narabyasli H. Clinical aspects of juvenile parkinsonism. Research progress in Parkinson's disease, F. C. Rose, R. Capildea. Pitman, Turnbridge Wells 1981; 35–39

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.